IMA201 Product: Clinical Trials

1 trial of IMA201 Product, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow IMA201 Product: new trials by email Literature Review of IMA201 Product trials Research Report on IMA201 Product

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)
IMA201 Product, IMADetect® - Solid Tumor, Cancer
Phase 1CompletedImmatics US, Inc.72018-12-192025-02-04

Conditions studied

Neoplasms (1)

Sponsors

Immatics US, Inc. (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Cedrik Britten, MD, PhD (1)

Results publications

PMID 29505699